Contents

Search

L-dopa decarboxylase in CSF

Indications: - evaluation of Parkinson's disease, Lewy body dementia & Parkinson-plus syndromes * L-dopa decarboxylase = aromatic L-amino acid decarboxylase

General

special chemistry test

References

  1. Pereira JB, Kumar A, Hall S et al DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging 2023. Sept 18 PMID: 37723208 https://www.nature.com/articles/s43587-023-00478-y